In the 2020 financial year, Group sales of MEDICLIN Aktiengesellschaft (MEDICLIN) of EUR 659.9 mill. were EUR 13.2 mill. or 2.0% below the previous year's value. The preliminary Group operating result is EUR 0.2 mill. (previous year: EUR 22.4 mill.).
Targets achieved despite the start of the 2nd wave of the pandemic at the end of the year
In April 2020, the original forecast for the 2020 financial year had to be withdrawn due to the corona pandemic, MEDICLIN published an outlook for 2020 at the beginning of November 2020. A continued positive development in patient intake with a stable infection rate was assumed. A decrease in sales in the Group of 2.0% and a Group operating result in the amount of the breakeven point were anticipated.
The effects of the pandemic have left their mark on business development
The effects of the corona pandemic left their mark on MEDICLIN's business development in 2020, despite the state protective shield and subsidies from the cost providers. In the first half of 2020 in particular, capacities were kept free for corona patients in both the acute clinics and the rehabilitation clinics. A slow ramp-up of capacities to normal operation under strict hygiene regulations allowed the capacity utilization to rise again somewhat in the second half of the year. At the end of the year, the strongly increasing number of infected people and the general reluctance of the population to undergo acute treatment in the current situation had a dampening effect on the occupancy rate in the rehabilitation clinics.
Fewer patients in the post-acute segment - Nursing segment stable
In the post-acute segment, sales fell by EUR 23.0 mill. or 5.5% to EUR 393.7 mill. (previous year: EUR 416.7 mill.). The preliminary segment result is EUR 4.8 mill. (previous year: EUR 23.1 mill.).
In the acute segment, sales of EUR 248.7 mill. were EUR 12.1 mill. or 5.1% above the previous year's figure (previous year: EUR 236.6 mill.). The preliminary segment result is EUR –1.5 mill. (previous year: EUR 1.6 mill.). The segment result is burdened by a one-off effect of EUR 1.4 mill. from a book value depreciation resulting from the sale of MediClin Krankenhaus am Crivitzer See GmbH, Crivitz, as of December 31, 2020.
The nursing care business area generated sales of EUR 15.8 mill. (previous year: EUR 15.3 mill.).
The number of staff rose slightly in 2020
The average number of full-time employees in 2020 was 7,471 full-time employees (previous year: 7,431 full-time employees). The number of trainees in the reporting year amounted to an average of 361 trainees (previous year: 328 trainees).
Sound financial structure
In the 2020 financial year, EUR 26.6 mill. (previous year: EUR 48.2 mill.) was invested in non-current assets (gross amount). A total of EUR 16.1 mill. (previous year: EUR 17.5 mill.) was spent on maintenance and repair. At the end of the year, liquid funds were above the previous year's value, mainly due to cost-cutting measures, deferred investment projects and liquidity inflows within the framework of the protective shield.
The equity ratio as of the balance sheet date was 19.9% (December 31, 2020: 21.2%).
The 2020 annual report will be available in German and English from March 26, 2021 at www.mediclin.de/investor-relations/finanzpublikationen/.
About MEDICLIN AG (Ticker: MED; WKN: 659 510)
MEDICLIN owns 35 clinics, seven nursing care facilities and ten medical care centres. The Group has about 8,350 beds/places and a headcount of about 10,300. With its strong network, MEDICLIN can offer its patients integrated care from the first visit to the doctor to surgery, post-operative rehabilitation and follow-up care at home. Doctors, therapists and nurses work together closely to achieve the best results. MEDICLIN plans the care of persons in need in accordance with their individual requirements and personal needs.
MEDICLIN – A company of the Asklepios Group.